Lena Claesson‐Welsh

Uppsala University

Papers

1

Total Citations

12

H-Index

1

About

Lena Claesson-Welsh is a leading figure in vascular biology, whose research has fundamentally advanced our understanding of angiogenesis—the formation of new blood vessels—and its role in cancer and inflammatory diseases. Her work has been instrumental in elucidating how vascular endothelial growth factor (VEGF) and its receptors control blood vessel growth and permeability, with profound implications for anti-angiogenic cancer therapies. Among her most cited contributions are seminal studies on VEGF receptor signal transduction and the mechanisms of vascular leakage, which have collectively garnered tens of thousands of citations. She has also pioneered the use of high-sensitivity isoelectric focusing to establish signaling biomarkers for colorectal cancer diagnosis, demonstrating her commitment to translating basic vascular biology into clinical tools. A highly decorated scientist, Claesson-Welsh is a member of the Royal Swedish Academy of Sciences and has received numerous international awards for her discoveries. Her work continues to shape therapeutic strategies targeting tumor vasculature, making her a pivotal figure for students and researchers interested in the intersection of cell signaling, vascular biology, and translational medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer
12 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Uppsala University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago